Uncovering the Truth: Inside the Scandal of Lincare’s Medicare Fraud

ProPublica’s investigation into Lincare, the largest distributor of home oxygen equipment in the United States, reveals a troubling pattern of Medicare fraud and misconduct. Despite multiple legal settlements totaling millions of dollars, Lincare continues to exploit the government and elderly patients.

The company has a history of overbilling Medicare, charging for equipment not in use, and violating laws against kickbacks. Lincare has been on probation four times since 2001, with little consequence beyond paying settlements that amount to pennies compared to its profits.

HHS, which oversees Medicare, has failed to take decisive action against Lincare, despite placing the company on probation multiple times. The agency’s reluctance to ban large suppliers like Lincare raises questions about its enforcement practices.

The investigation also uncovers a sales culture at Lincare that prioritizes profit over patient care. Employees are pressured to sell unnecessary products, and billing practices often exploit patients and Medicare.

Whistleblowers, such as former employees Brandon Haugen and Ben Montgomery, have shed light on Lincare’s fraudulent practices. Their efforts led to a $29 million settlement in 2023, but the company’s misconduct had been ongoing for years.

The article highlights the challenges of regulating Medicare equipment providers and the need for stronger enforcement measures. Despite efforts to curb fraud, Medicare fraud remains a significant concern, with billions lost to fraudulent schemes each year.

The story of Lincare serves as a cautionary tale about the consequences of weak oversight and the importance of holding companies accountable for their actions. It raises questions about the government’s response to Medicare fraud and the need for stricter regulations to protect patients and taxpayers.